Nykode Therapeutics ASA Stock: price and insider trades · Norway

Nykode Therapeutics ASA belongs to the Health Care sector. Filings by its managers are published through Oslo Børs. The last twelve months, up to 18 October 2026, brought 5 filings signed by 4 insiders.

The flow runs one way only: 1 insider bought (1 purchase totalling €8,490) and nobody sold on the market. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The largest single trade was a purchase of €8,490 by Michael Engsig, published on 24 November 2025.

The most recent open-market purchase was published on 24 November 2025, 327 days ago.

Across the 258 companies tracked on its exchange, the median is 4 filings; at 5 filings, this issuer sits above that mark. Looking back to 2021, when coverage begins, insiders filed 23 purchases and 9 sales.

For comparison within the same sector, see the insider buying recorded at Cooper Companies, Inc. and Anixa Biosciences Inc. These figures are compiled from regulatory filings published by Oslo Børs. They describe what insiders did and are not a recommendation.